Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma
- PMID: 2418689
- PMCID: PMC1888093
Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma
Abstract
The diagnosis of adrenocortical carcinoma (ACC) is often difficult, because this tumor may present with direct extension into adjacent renal parenchyma or with metastatic disease. Renal cell carcinoma and other histologically similar tumors are potentially confused with ACC by conventional light microscopy, and their separation from the latter is often impossible without the aid of additional studies. Furthermore, the distinction between adrenal cortical adenoma and ACC may also be problematic. Because of these factors, the authors studied 10 cases each of ACC, adrenocortical adenoma, and renal cell carcinoma (RCC) immunohistochemically, in an attempt to develop objective parameters which may aid in this differential diagnostic dilemma. Nontrypsinized, formalin-fixed, paraffin-embedded specimens were used in all cases, and tissue from the adrenocortical tumors was also studied for intermediate filament content after protease digestion. All 20 nontrypsinized adrenocortical neoplasms were positive for vimentin, but not for cytokeratin, epithelial membrane antigen, or blood group isoantigens. Conversely, each of 10 cases of RCC expressed epithelial membrane antigen, cytokeratin, and blood group isoantigens, but none was immunoreactive for vimentin. Two adrenocortical carcinomas and three adenomas manifested cytokeratin positivity after trypsin digestion. There were no significant differences between the immunostaining profiles of ACC and adrenocortical adenoma, which suggest that this distinction must still rely upon clinical and morphologic criteria.
Similar articles
-
Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.Mod Pathol. 1993 Jan;6(1):36-41. Mod Pathol. 1993. PMID: 7678935
-
Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.Cancer. 1999 Jun 25;87(3):168-72. Cancer. 1999. PMID: 10385449
-
Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.Mod Pathol. 1999 Apr;12(4):351-5. Mod Pathol. 1999. PMID: 10229498
-
[Renal cell carcinoma associated with renal angiomyolipoma and renal cortical adenoma].Arch Esp Urol. 2000 Mar;53(2):164-7. Arch Esp Urol. 2000. PMID: 10802923 Review. Spanish.
-
[Ectopic adrenal cortical adenoma in the spinal canal: A case report and a review of the literature].Arkh Patol. 2016 May-Jun;78(3):44-48. doi: 10.17116/patol201678344-48. Arkh Patol. 2016. PMID: 27296006 Review. Russian.
Cited by
-
Expression of the human nephron differentiation molecules in renal cell carcinomas.Am J Pathol. 1990 Oct;137(4):895-905. Am J Pathol. 1990. PMID: 1699423 Free PMC article.
-
Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.J Cancer Res Clin Oncol. 1992;119(1):49-54. doi: 10.1007/BF01209488. J Cancer Res Clin Oncol. 1992. PMID: 1400566 Free PMC article.
-
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.Int J Surg Pathol. 2023 Sep;31(6):927-938. doi: 10.1177/10668969221117243. Epub 2022 Aug 9. Int J Surg Pathol. 2023. PMID: 35946088 Free PMC article.
-
Monoclonal Antibodies Recognizing Normal and Neoplastic Human Adrenal Cortex.Endocr Pathol. 1995 Spring;6(1):21-34. doi: 10.1007/BF02914986. Endocr Pathol. 1995. PMID: 12114687
-
An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.Adv Anat Pathol. 2020 May;27(3):114-163. doi: 10.1097/PAP.0000000000000256. Adv Anat Pathol. 2020. PMID: 32205473 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical